TESLA WATCH: Elon Musk Pay Deal In Focus Metsera (MTSR) called Pfizer's (PFE) claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk (NVO) over their proposed merger. The company's statement is the most recent salvo in a battle that began last week when Novo made an unsolicited $6.5 billion bid to buy Metsera. Metsera, an obesity-focused biotech company, had already agreed to a smaller$4.9 billion deal with Pfizer. Pfizer is suing the duo, claiming Novo is trying to st ...